Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Kenneth Shain

Kenneth Shain

MD, PhD
Moffitt Cancer Center
Phase II study of Dara-based response-adapted therapy for older adults with newly diagnosed myeloma 4:28
Phase II study of Dara-based response-adapted therapy for older adults with newly diagnosed myeloma
Kenneth Shain • 31 Jan 2025
Future directions in the management of frail patients with myeloma 1:40
Future directions in the management of frail patients with myeloma
Kenneth Shain • 31 Jan 2025
Genomic determinants of resistance to anti-BCMA CAR-T in patients with R/R myeloma 1:54
Genomic determinants of resistance to anti-BCMA CAR-T in patients with R/R myeloma
Kenneth Shain • 31 Jan 2025
Modeling novel drug and management strategies in multiple myeloma 3:25
Modeling novel drug and management strategies in multiple myeloma
Kenneth Shain • 31 Jan 2025
Why use model systems for multiple myeloma research? 11:15
Why use model systems for multiple myeloma research?
Enrique Ocio et al. • 18 Oct 2017
The content of VJHemOnc is intended for healthcare professionals